CD4 and cryptococcosis: Previously, HIV-associated cryptococcal infections have been a major concern, with an estimated global prevalence of cryptococcal antigenemia of 4.4% among HIV patients with CD4+ counts <200 cells/μL, corresponding to approximately 179,000 cases in 2020.